A
83/100
Intellia Therapeutics Empresa Reclamada
Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat cancer and immunological diseases, or can replace patients’ diseased cells. The combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. leer más
HR or Marketing? Claim Your Free Employer Account
Intellia Therapeutics Outlook Employee Reviews
All
Positive
Constructive
¿Qué te hace más feliz en el trabajo?
How much emphasis there is on learning
Revisión Publicado hace 3 años
¿Qué está mal y cómo se puede mejorar?
There aren't any Outlook reviews of Intellia Therapeutics yet.
Be the first to contribute a review.
¿Qué es lo que más te gusta de tu empresa?
There aren't any Outlook reviews of Intellia Therapeutics yet.
Be the first to contribute a review.
¿Qué es lo que más te gustaría ver mejorado en tu empresa?
There aren't any Outlook reviews of Intellia Therapeutics yet.
Be the first to contribute a review.
×